DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...

Many leaders face difficulties when it comes to getting their teams to communicate and collaborate effectively. Advanced AI ...

Antibiotic resistance is one of the most pressing—and quietly advancing—challenges facing modern medicine. Among the most ...

Detailed price information for Biomark Diagnostics Inc (BUX-CN) from The Globe and Mail including charting and trades.

A research team led by Senior Researcher Chanyong Park, Principal Researcher Dongkyu Lee, and Postdoctoral Researcher Changha ...

Trial sponsors are typically responsible for providing the experimental drug or treatment at no cost to patients. However, ...

Haiti faces a severe security and humanitarian crisis, with ongoing economic contraction, high inflation, and collapsing ...

Caris Life Sciences, Inc. is rated a Hold with positive EBITDA & free cash flow driven by strong MI segment performance. Read ...

A study conducted by Iowa State University researchers, in partnership with the National Animal Disease Center, suggests bird ...

No one's crossed the finishing line yet, but drug developer Nyrada is leading the Great Biotech Regatta of 2025 with close to ...

A multinational team revises the SOFA score to reflect modern organ support, validates it across diverse ICUs, and guides ...